Anthony Wayne Orr

Anthony Wayne Orr

Auto-generated profile, based on publicly available information

Anthony Wayne Orr

Department of Pathology and Translational Pathobiology, Louisiana State University Health Sciences Center, Shreveport, LA

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2006 in Developmental Cell
Verified
Journal Article
Closed access
AOA. Wayne Orr
A. Wayne Orr
BHBrian P. Helmke
Brian P. Helmke
BBBrett R. Blackman
Brett R. Blackman
MSMartin A. Schwartz
Martin A. Schwartz

1 March 2004 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
AKAkira Katsumi
Akira Katsumi
AOA. Wayne Orr
A. Wayne Orr
ETEleni Tzima
Eleni Tzima
MSMartin Alexander Schwartz
Martin Alexander Schwartz
Mechanical forces are crucial to the regulation of cell and tissue morphology and function. At the cellular level, forces influence cytoskeletal organization, gene expression, proliferation, and survival. Integrin-mediated adhesions are intrinsically mechanosensitive and a large body of data implicates integrins in sensing mechanical forces. We review the relationship between integrins and mechanical forces, the role of integrins in cellular responses to stretch and fluid flow, and propose that some of these events are mechanistically related.

1 September 2019 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
Christopher G KevilChristopher G Kevil
Christopher G Kevil
NGNicholas E. Goeders
Nicholas E. Goeders
MWMatthew D. Woolard
Matthew D. Woolard
SBShenuarin Bhuiyan
Shenuarin Bhuiyan
PDPaari Dominic
Paari Dominic
AOA. Wayne Orr
A. Wayne Orr
While the opioid epidemic has garnered significant attention, the use of methamphetamines is growing worldwide independent of wealth or region. Following overdose and accidents, the leading cause of death in methamphetamine users is cardiovascular disease, because of significant effects of methamphetamine on vasoconstriction, pulmonary hypertension, atherosclerotic plaque formation, cardiac arrhythmias, and cardiomyopathy. In this review, we examine the current literature on methamphetamine-induced changes in cardiovascular health, discuss the potential mechanisms regulating these varied effects, and highlight our deficiencies in understanding how to treat methamphetamine-associated cardiovascular dysfunction.

4 April 2005 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
AOA. Wayne Orr
A. Wayne Orr
JSJohn M. Sanders
John M. Sanders
MBMelissa Bevard
Melissa Bevard
ECElizabeth Coleman
Elizabeth Coleman
ISIan J. Sarembock
Ian J. Sarembock
MSMartin Alexander Schwartz
Martin Alexander Schwartz
Atherosclerotic plaque forms in regions of the vasculature exposed to disturbed flow. NF-κB activation by fluid flow, leading to expression of target genes such as E-selectin, ICAM-1, and VCAM-1, may regulate early monocyte recruitment and fatty streak formation. Flow-induced NF-κB activation is downstream of conformational activation of integrins, resulting in new integrin binding to the subendothelial extracellular matrix and signaling. Therefore, we examined the involvement of the extracellular matrix in this process. Whereas endothelial cells plated on fibronectin or fibrinogen activate NF-κB in response to flow, cells on collagen or laminin do not. In vivo, fibronectin and fibrinogen are deposited at atherosclerosis-prone sites before other signs of atherosclerosis. Ligation of integrin α2β1 on collagen prevents flow-induced NF-κB activation through a p38-dependent pathway that is activated locally at adhesion sites. Furthermore, altering the extracellular matrix to promote p38 activation in cells on fibronectin suppresses NF-κB activation, suggesting a novel therapeutic strategy for treating atherosclerosis.

22 October 2009 in Journal of Vascular Research
Verified
Journal Article
Open access
PDF file
AOAnthony Wayne Orr
Anthony Wayne Orr
NHNicole E. Hastings
Nicole E. Hastings
BBBrett R. Blackman
Brett R. Blackman
BWBrian R. Wamhoff
Brian R. Wamhoff
Vascular smooth muscle cell (SMC) phenotypic modulation plays a key role in atherosclerosis and is classically defined as a switch from a ‘contractile’ phenotype to a ‘synthetic’ phenotype, whereby genes that define the contractile SMC phenotype are suppressed and proliferation and/or migratory mechanisms are induced. There is also evidence that SMCs may take on a ‘proinflammatory’ phenotype, whereby SMCs secrete cytokines and express cell adhesion molecules, e.g. IL-8, IL-6, and VCAM-1, respectively, which may functionally regulate monocyte and macrophage adhesion and other processes during atherosclerosis. Factors that drive the inflammatory phenotype are not limited to cytokines but also include hemodynamic forces imposed on the blood vessel wall and intimate interaction of endothelial cells with SMCs, as well as changes in matrix composition in the vessel wall. However, it is critical to recognize that our understanding of the complex interaction of these multiple signal inputs has only recently begun to shed light on mechanisms that regulate the inflammatory SMC phenotype, primarily through models that attempt to recreate this environment ex vivo. The goal of this review is to summarize our current knowledge in this area and identify some of the key unresolved challenges and questions requiring further study.

14 February 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CAChowdhury S. Abdullah
Chowdhury S. Abdullah
Shafiul AlamShafiul Alam
Shafiul Alam
RARicha Aishwarya
Richa Aishwarya
SMSumitra Miriyala
Sumitra Miriyala
MBMohammad Alfrad Nobel Bhuiyan
Mohammad Alfrad Nobel Bhuiyan
MBMd. Shenuarin Bhuiyan
Md. Shenuarin Bhuiyan
Doxorubicin (Dox) is a highly effective anticancer drug but cause acute ventricular dysfunction, and also induce late-onset cardiomyopathy and heart failure. Despite extensive studies, the pathogenic sequelae leading to the progression of Dox-associated cardiomyopathy remains unknown. We assessed temporal changes in autophagy, mitochondrial dynamics, and bioenergetics in mouse models of acute and chronic Dox-cardiomyopathy. Time course study of acute Dox-treatment showed accumulation of LC3B II in heart lysates. Autophagy flux assays confirmed that the Dox-induced accumulation of autophagosomes occurs due to blockage of the lysosomal degradation process. Dox-induced autophagosomes and autolysosome accumulation were confirmed in vivo by using GFP-LC3 and mRFP-GFP-LC3 transgenic (Tg) mice. Mitochondria isolated from acute Dox-treated hearts showed significant suppression of oxygen consumption rate (OCR). Chronic Dox-cardiotoxicity also exhibited time-dependent accumulation of LC3B II levels and increased accumulation of green puncta in GFP-LC3 Tg hearts. Mitochondria isolated from chronic Dox-treated hearts also showed significant suppression of mitochondrial OCR. The in vivo impairment of autophagic degradation process and mitochondrial dysfunction data were confirmed in vitro using cultured neonatal cardiomyocytes. Both acute and chronic Dox-associated cardiomyopathy involves a multifocal disease process resulting from autophagosomes and autolysosomes accumulation, altered expression of mitochondrial dynamics and oxidative phosphorylation regulatory proteins, and mitochondrial respiratory dysfunction.